Solar Urticaria: An Ambispective Study in a Long-term Follow-up Cohort with Emphasis on Therapeutic Predictors and Outcomes.

Publication Year: 2024

DOI:
10.2340/actadv.v104.25576

PMCID:
PMC10789168

PMID:
38189220

Journal Information

Full Title: Acta Derm Venereol

Abbreviation: Acta Derm Venereol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Sexually Transmitted Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest AMG-A is, or recently was, a speaker and/or advisor for and/or has received research funding from Almirall, Amgen, AstraZeneca, Avene, Celldex, Escient Pharmaceutials, Genentech, GSK, Instituto Carlos III- FEDER, Leo Pharma, Menarini, Mitsubishi Tanabe Pharma, Novartis, Sanofi–Regeneron, Servier, Thermo Fisher Scientific, Uriach Pharma / Neucor, outside the submitted work. David Pesqué benefits from a research grant of Leo-Pharma, outside the submitted work. All other authors have no conflicts of interest to declare."

Evidence found in paper:

"Ethics approval for the study was granted by the local Clinical Research Ethics Committee (2012/4913/I). An informed consent was signed by all patients."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025